Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death (Q35008349)

5 August 2017

title

Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death (English)

1 reference

5 August 2017

0 references

multiple drug resistance

1 reference

multidrug-resistant tuberculosis

inferred from title

1 reference

Galina Yanova

8

0 references

Gustavo E. Velásquez

object named as

Gustavo E Velásquez

1

0 references

Molly F Franke

object named as

Molly F Franke

11

0 references

Mercedes C. Becerra

2

object named as

Mercedes C Becerra

1 reference

5 August 2017

Irina Y Gelmanova

3

1 reference

5 August 2017

Alexander D Pasechnikov

4

1 reference

5 August 2017

Askar Yedilbayev

5

1 reference

5 August 2017

Sonya S Shin

6

1 reference

5 August 2017

Yevgeny G Andreev

7

1 reference

5 August 2017

Sidney S Atwood

9

1 reference

5 August 2017

Carole D Mitnick

10

1 reference

5 August 2017

Michael L Rich

12

1 reference

5 August 2017

Salmaan Keshavjee

13

1 reference

5 August 2017

language of work or name

English

0 references

publication date

11 April 2014

1 reference

Clinical Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

59

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

9-15

1 reference

Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Immunological biomarkers of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Programmes and principles in treatment of multidrug-resistant tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Increased levels of circulating interleukin-18 in patients with advanced tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305127

Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease

8 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU209

Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU209

Immunotherapy for tuberculosis: wave of the future or tilting at windmills?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU209

Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU209

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU209

Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB

21 January 2018

1 reference

12 December 2020

Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis

1 reference

12 December 2020

Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility

1 reference

12 December 2020

Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia

1 reference

12 December 2020

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia

1 reference

12 December 2020

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

1 reference

12 December 2020

Picking Up the Pace — Scale-Up of MDR Tuberculosis Treatment Programs

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIU209

1 reference

release_lhok3jk2tjgmjictuecdog2c6m

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lhok3jk2tjgmjictuecdog2c6m

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4305127

1 reference

5 August 2017

1 reference